These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 24587647)

  • 1. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
    Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
    World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.
    Xing YN; Xu XY; Nie XC; Yang X; Yu M; Xu HM; Liu YP; Takano Y; Zheng HC
    Hum Pathol; 2012 Dec; 43(12):2299-307. PubMed ID: 22863086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules.
    Ullah A; Zhao J; Li J; Singla RK; Shen B
    Life Sci; 2024 Jan; 336():122277. PubMed ID: 37995936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CXC chemokines and their receptors in the progression and treatment of tumors.
    Zhu Q; Han X; Peng J; Qin H; Wang Y
    J Mol Histol; 2012 Dec; 43(6):699-713. PubMed ID: 22752457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
    Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
    Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
    Bikfalvi A; Billottet C
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3, a double-edged sword in tumor progression and angiogenesis.
    Billottet C; Quemener C; Bikfalvi A
    Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-C motif chemokine receptors in gastric cancer.
    Ryu H; Baek SW; Moon JY; Jo IS; Kim N; Lee HJ
    Mol Clin Oncol; 2018 Jan; 8(1):3-8. PubMed ID: 29285394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
    Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
    Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.
    Lee HS; Hong JE; Kim EJ; Kim SH
    Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine network in cancer--much more than directing cell movement.
    Kulbe H; Levinson NR; Balkwill F; Wilson JL
    Int J Dev Biol; 2004; 48(5-6):489-96. PubMed ID: 15349823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
    Vilgelm AE; Richmond A
    Front Immunol; 2019; 10():333. PubMed ID: 30873179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
    Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
    Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.